{"transactions":[{"id":1289688,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":83737,"kind":"person","name":"Huhn Stephen L.","position":1,"cik":"0001863904","reported_name":"Huhn Stephen L.","relationship":{"officer":true,"officer_title":"CMO & Sr VP, Clinical Dev."}}],"security":"Stock Option (right to buy)","published_at":"2025-01-31T16:38:01.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service."}],"balance_after":110000,"derivative":{"exercise_price":9.79,"expiration_date":"2035-01-30","underlying":"Class A Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001437749-25-002429","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863904/000143774925002429/rdgdoc.xml","form_type":"4"}},{"id":1433870,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":83737,"kind":"person","name":"Huhn Stephen L.","position":1,"cik":"0001863904","reported_name":"Huhn Stephen L.","relationship":{"officer":true,"officer_title":"CMO & Sr VP, Clinical Dev."}}],"security":"Stock Option (right to buy)","published_at":"2024-08-14T18:03:27.000Z","date":"2024-08-13","kind":"exercise","planned":false,"acquired":false,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options granted under the Issuer's 2012 Equity Incentive Plan. The option is fully vested."}],"balance_after":161394,"derivative":{"exercise_price":1.01,"expiration_date":"2030-02-24","underlying":"Class A Common Stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0001437749-24-026903","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863904/000143774924026903/rdgdoc.xml","form_type":"4"}},{"id":1433869,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":83737,"kind":"person","name":"Huhn Stephen L.","position":1,"cik":"0001863904","reported_name":"Huhn Stephen L.","relationship":{"officer":true,"officer_title":"CMO & Sr VP, Clinical Dev."}}],"security":"Class A Common Stock","published_at":"2024-08-14T18:03:27.000Z","date":"2024-08-13","kind":"exercise","planned":false,"acquired":true,"shares":12800,"price":1.01,"value":12928.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of Class A Common Stock."}],"balance_after":12800,"source":{"system":"sec-edgar","filing":"0001437749-24-026903","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863904/000143774924026903/rdgdoc.xml","form_type":"4"}},{"id":1499305,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":83737,"kind":"person","name":"Huhn Stephen L.","position":1,"cik":"0001863904","reported_name":"Huhn Stephen L.","relationship":{"officer":true,"officer_title":"CMO & Sr VP, Clinical Dev."}}],"security":"Stock Option (right to buy)","published_at":"2024-05-29T17:56:53.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on April 5, 2025, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service."}],"balance_after":100000,"derivative":{"exercise_price":15.76,"expiration_date":"2034-05-23","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-24-018623","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863904/000143774924018623/rdgdoc.xml","form_type":"4"}}]}